$ORRF

Orrstown Financial Services Inc (NASDAQ:ORRF) Short Interest Down 16.5% in December

Orrstown Financial Services Inc (NASDAQ:ORRF) experienced a 16.5% decrease in short interest during December, totaling 326,306 shares as of December 15th. This represents about 1.8% of the company's float, with a days-to-cover ratio of 0.8 days. The stock trades at $35.49, has a market capitalization of $692.1 million, and analysts have a consensus "Moderate Buy" rating with an average target price of $39.25.

Original reporting
MarketBeat · MarketBeat
Published Jan 1, 2026, 4:09 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jan 1, 2026, 4:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Orrstown Financial Services Inc (NASDAQ:ORRF) Short Interest Down 16.5% in December — source image
Decision brief

The 30-second read

$ORRFBullishMed
01

Why it matters

The decline in short interest suggests reduced bearish pressure, potentially leading to upward price movement, especially if accompanied by positive earnings or macroeconomic indicators.

02

Market read

The news is relevant for traders and investors focusing on regional banks and financial sector dynamics, with potential short-term trading opportunities.

03

What to watch

Potential upcoming earnings reports or macroeconomic events could override current technical signals and influence stock performance.

Relevance 6/10Timing: Immediate to short-term (within 1-2 weeks)

Background

Orrstown Financial Services Inc experienced a notable decrease in short interest during December, indicating a possible shift in market sentiment.

Company-level read

Ticker impact

$ORRFBullishMedium confidence
Context

The news about a significant decrease in short interest for Orrstown Financial Services Inc (NASDAQ:ORRF) suggests a potential bullish sentiment among traders and investors.

Expected impact

Moderate upward price movement in the short term, approximately 2-4%.

Evidence & confidence

The decrease in short interest, coupled with a relatively low days-to-cover ratio, suggests reduced bearish pressure. However, the overall market sentiment remains somewhat cautious, and external factors could influence the stock's movement.

Market effects

The decrease in short interest for a regional bank like ORRF may reflect broader positive sentiment in the regional banking sector.

Limited; primarily affects investors focused on regional banks in the Mid-Atlantic region.

Negligible; the news is specific to a regional financial institution and does not significantly impact global markets.

Counterpoint

The reduction in short interest could be a temporary correction or a sign of short covering rather than a fundamental shift in sentiment.

Key entities

  • Orrstown Financial Services Inc

    A regional bank providing banking and financial services in the Mid-Atlantic region.

Related articles

$ORRFMed

Orrstown Financial Services, Inc. Reports Second Quarter 2026 Results

ORRSTOWN FINANCIAL SERVICES INC (ORRF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex9912026-q2earningsrelease.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE: Orrstown Financial Services, Inc. Reports Second Quarter 2026 Results • Net income of $21.2 million, or $1.09 per diluted share, for the three months ended June 30, 2026 compared to net

$RAREHighAI 9/10

Ultragenyx agrees to sell voucher for US$210M

Ultragenyx Pharmaceutical (NASDAQ: RARE) agreed to sell a rare pediatric disease priority review voucher for $210M, nearly half its cash reserves. The deal, subject to regulatory approval, follows the FDA's August approval of its Genglycos gene therapy. Shares rose 2.97% on the news. Ultragenyx plans to use proceeds to advance rare disease therapies and support profitability. The price is within the range of recent voucher transactions, such as Rocket Pharmaceuticals' $180M deal.

$SLBMed

How New Energy Contracts Will Impact SLB (SLB) Stock

SLB (SLB) secured multi-year energy contracts with Aramco and ExxonMobil, expanding its backlog in onshore and deepwater infrastructure. Analysts project $43.0b revenue and $5.5b earnings by 2029, with potential upside. The company's focus on digital and data center solutions is seen as a driver for higher revenue.

$CEGMed

Big Tech Keeps Signing Nuclear Deals With the Same Company. Here's Who It Is and Why That Matters More Than Any Single Deal.

Constellation Energy (CEG) signed a deal with Alphabet's Google to supply 890 MW of nuclear power, highlighting its role in powering AI growth for tech giants. CEG operates outside regulated utilities, offering direct power sales to companies like Microsoft, Meta, and Amazon. Its scale, diverse energy portfolio, and long-term contracts support growth, though its stock remains 25% below 2025 highs.

$LCIDMed

Lucid Builds Fewer EVs Than It Sells As CEO’s Cash-Preservation Reset Takes Hold

Lucid Group reported Q3 production of 2,954 EVs and deliveries of 3,806, down from last year. The company is reducing inventory and aligning output with demand under CEO Silvio Napoli's operational reset. Lucid aims to improve cash flow by $1.4B in 2026. Analysts expect a Q3 loss of $2.30 per share and revenue of $570.42M. The stock has a Hold consensus rating with an average price target of $10.20.